DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
75.19
-0.05 (-0.07%)
Nov 21, 2024, 2:03 PM EST - Market open
DexCom Analyst Ratings
Total Analysts
17
Consensus Rating
Buy
Price Target
$101.29
Upside
+34.71%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bernstein | Bernstein | Buy Maintains $82 → $86 | Buy | Maintains | $82 → $86 | +14.38% | Oct 25, 2024 |
| Raymond James | Raymond James | Strong Buy Maintains $115 → $99 | Strong Buy | Maintains | $115 → $99 | +31.67% | Oct 25, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $120 → $115 | Buy | Maintains | $120 → $115 | +52.95% | Oct 25, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $115 → $105 | Buy | Maintains | $115 → $105 | +39.65% | Oct 25, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $75 → $85 | Hold | Maintains | $75 → $85 | +13.05% | Oct 25, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $90 → $87 | Buy | Maintains | $90 → $87 | +15.71% | Oct 25, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $80 → $90 | Buy | Maintains | $80 → $90 | +19.70% | Oct 25, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $130 → $120 | Buy | Maintains | $130 → $120 | +59.59% | Oct 8, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $90 | Buy | Reiterates | $90 | +19.70% | Aug 26, 2024 |
| Stifel | Stifel | Strong Buy Maintains $90 → $100 | Strong Buy | Maintains | $90 → $100 | +33.00% | Aug 23, 2024 |
| Baird | Baird | Hold Maintains $80 → $82 | Hold | Maintains | $80 → $82 | +9.06% | Aug 5, 2024 |
| Barclays | Barclays | Hold Maintains $138 → $113 | Hold | Maintains | $138 → $113 | +50.29% | Jul 29, 2024 |
| Baird | Baird | Buy → Hold Downgrades $161 → $80 | Buy → Hold | Downgrades | $161 → $80 | +6.40% | Jul 26, 2024 |
| BTIG | BTIG | Strong Buy Maintains $156 → $120 | Strong Buy | Maintains | $156 → $120 | +59.59% | Jul 26, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $120 → $75 | Hold | Maintains | $120 → $75 | -0.25% | Jul 26, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $150 → $115 | Buy | Maintains | $150 → $115 | +52.95% | Jul 26, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.